nach oben

Erschienen in:

30.09.2020 | Original articles

Heart failure with preserved ejection fraction, atrial fibrillation, and increased NT‑proBNP levels

An emergent clinical dilemma

verfasst von: Ebru Ipek Turkoglu, MD, PhD, Emine Cigdem Kircicegi Cicekdag, MD, PhD

Erschienen in: Herz | Sonderheft 2/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

The co-presence of atrial fibrillation (AF) in patients with heart failure with preserved ejection fraction (HFpEF) may cause some diagnostic difficulties, because AF itself is associated with elevated levels of N‑terminal pro-B-type natriuretic peptide (NT-proBNP). In the present study we aimed to investigate NT-proBNP levels of patients with HFpEF and AF.

Methods

This was a retrospective cohort study. Outpatient data were reviewed through the hospital data management system. Consecutive patients with the diagnosis of HFpEF and AF, who had at least one NT-proBNP measurement, were included in the study.

Results

The study population comprised 235 patients. Median NT-proBNP levels were 1242 pg/ml in the stable phase and 2321.5 pg/ml during decompensation. NT-proBNP was correlated positively with age, CHA₂DS₂ and CHA₂DS₂VASc scores, left atrial diameter (LAD), tricuspid annulus diameter, and systolic pulmonary artery pressure but negatively correlated with left ventricular ejection fraction (LVEF) and hemoglobin level. The change in NT-proBNP was positively correlated with heart rate and LAD.

Conclusion

Patients with HFpEF and AF have higher levels of NT-proBNP, which may exceed the upper limits defined in guidelines. This study underlines the importance of measuring NT-proBNP levels in the stable phase and proposes a rule-in level for the decompensated phase.

Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 37:2129–2200. https://doi.org/10.1093/eurheartj/ehw128CrossRefPubMed

Heart Failure Association of the European Society of Cardiology, Mueller C, McDonald K, de Boer RA, Maisel A, Cleland JGF, Kozhuharov N et al (2019) Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations. Eur J Heart Fail 21:715–731. https://doi.org/10.1002/ejhf.1494CrossRef

Pfeffer MA, Shah AM, Borlaug BA (2019) Heart failure with preserved ejection fraction in percpectice. Circ Res 124:1598–1617. https://doi.org/10.1161/CIRCRESAHA.119.313572CrossRefPubMedPubMedCentral

Ho JE, Enserro D, Brouwers FP, Kizer JR, Shah SJ, Psaty BM et al (2016) Predicting heart failure with pre-served and reduced ejection fraction: the International Collaboration on Heart Failure Subtypes. Circ Heart Fail 9:e3116CrossRefPubMed

Borlaug BA, Jaber WA, Ommen SR, Lam CS, Redfield MM, Nishimura RA (2011) Diastolic relaxation and compliance reserve during dynamic exercise in heart failure with preserved ejection fraction. Heart 97:964–969. https://doi.org/10.1136/hrt.2010.212787CrossRefPubMed

Westermann D, Kasner M, Steendijk P, Spillmann F, Riad A, Weitmann K et al (2008) Role of left ventricular stiffness in heart failure with normal ejection fraction. Circulation 117:2051–2060. https://doi.org/10.1161/CIRCULATIONAHA.107.716886CrossRefPubMed

Cheng CP, Noda T, Nozawa T, Little WC (1993) Effect of heart failure on the mechanism of exercise-induced augmentation of mitral valve flow. Circ Res 72:795–806CrossRefPubMed

Davie P, Francis CM, Caruana L, Sutherland GR, McMurray JJ (1997) Assessing diagnosis in heart failure: which features are any use? QJM 90:335–339CrossRefPubMed

Mant J, Doust J, Roalfe A, Barton P, Cowie MR, Glasziou P et al (2009) Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care. Health Technol Assess 13:1–207, iiiCrossRefPubMed

10.

Oudejans I, Mosterd A, Bloemen JA, Valk MJ, Van Velzen E, Wielders JP et al (2011) Clinical evaluation of geriatric outpatients with suspected heart failure: value of symptoms, signs, and additional tests. Eur J Heart Fail 13:518–527CrossRefPubMed

11.

Fonseca C (2006) Diagnosis of heart failure in primary care. Heart Fail Rev 11:95–107CrossRefPubMed

12.

Kelder J, Cramer M, van Wijngaarden J, van Tooren R, Mosterd A, Moons KGM et al (2011) The diagnostic value of physical examination and additional testing in primary care patients with suspected heart failure. Circulation 124:2865–2873CrossRefPubMed

13.

Boonman-de Winter LJM, Rutten FH, Cramer MJ, Landman MJ, Zuithoff NPA, Liem AH et al (2015) Efficiently screening heart failure in patients with type 2 diabetes. Eur J Heart Fail 17:187–195CrossRefPubMed

14.

Reddy YNV, Carter RE, Obokata M, Redfield MM, Borlaug BA (2018) A simple evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction. Circulation 138:861–870. https://doi.org/10.1161/CIRCULATIONAHA.118.034646CrossRefPubMedPubMedCentral

15.

Rutten FH, Taylor CJ, Brouwer JR, Hobbs R, EPCCS Board (2016) Practical guidance on heart failure diagnosis and management in primary care. Eur J Prev Cardiol 23(5):460–473CrossRefPubMed

16.

Data established with the Elecsys proBNP assay (first generation, REF 03121640122). Elecsys proBNP II Cobas^® Roche Diagnostics GmbH.

17.

18.

Morello A, Lloyd-Jones DM, Chae CU, van Kimmenade RRJ, Chen AC, Baggish AL et al (2007) Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: results from the ProBNP investigation of dyspnea in the Emergency Department (PRIDE) study. Am Heart J 153:90–97CrossRefPubMed

19.

Gould PA, Gula LJ, Bhayana V, Subbiah RN, Bentley C, Yee R et al (2010) Characterization of cardiac brain natriuretic peptide release in patients with paroxysmal atrial fibrillation undergoing left atrial ablation. Circ Arrhythm Electrophysiol 3:18–23CrossRefPubMed

20.

Santema BT, Chan MM, Tromp J, Dokter M, van der Wal HH, Emmens JE et al (2019) The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure. Clin Res Cardiol. https://doi.org/10.1007/s00392-019-01513-yCrossRefPubMedPubMedCentral

21.

Lam CSP, Rienstra M, Tay WT, Liu LCY, Hummel YM, van der Meer P et al (2017) Atrial fibrillation in heart failure with preserved ejection fraction. Association with exercise capacity, left ventricular filling pressures, natriuretic peptides and left atrial volume. JACC Heart Fail 5(2):92–98. https://doi.org/10.1016/j.jchf.2016.10.005CrossRefPubMed

22.

Zakeri R, Borlaug BA, McNulty S, Mohammed SF, Lewis GD, Semigran MJ et al (2014) Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study. Circ Heart Fail 7:123–130. https://doi.org/10.1161/CIRCHEARTFAILURE.113.000568CrossRefPubMed

23.

SOCRATES Investigators and Coordinators, Pieske B, Butler J, Filippatos G, Lam C, Maggioni AP, Ponikowski P et al (2014) Rationale and design of the SOluble guanylate Cyclase stimulatoR in heArT failurE Studies (SOCRATES). Eur J Heart Fail 16:1026–1038. https://doi.org/10.1002/ejhf.135CrossRef

24.

Santema B, Kloosterman M, van Gelder IC, Mordi I, Lang CC, Lam CSP et al (2018) Comparing biomarker profiles of patients with heart failure: atrial fibrillation vs. sinus rhythm and reduced vs. preserved ejection fraction. Eur Heart J 39:3867–3875. https://doi.org/10.1093/eurheartj/ehy421CrossRefPubMed

25.

Voors AA, Anker SD, Cleland JG, Dickstein K, Filippatos G, van der Harst P et al (2016) BIOlogy Study to TAilored Treatment in Chronic Heart Failure: rationale, design and baseline characteristics of BIOSTAT-CHF. Eur J Heart Fail 18:716–726. https://doi.org/10.1002/ejhf.531CrossRefPubMed

Titel: Heart failure with preserved ejection fraction, atrial fibrillation, and increased NT‑proBNP levels
An emergent clinical dilemma
verfasst von: Ebru Ipek Turkoglu, MD, PhD
Emine Cigdem Kircicegi Cicekdag, MD, PhD
Publikationsdatum: 30.09.2020
Verlag: Springer Medizin
Erschienen in: Herz / Ausgabe Sonderheft 2/2021
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI: https://doi.org/10.1007/s00059-020-04981-5

Neu im Fachgebiet Kardiologie

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Background

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Sonderheft 2/2021

Pulmonary hypertension due to left heart disease with pulmonary arterial wedge pressure ≤15 mm Hg

Genetic association between eNOS gene polymorphisms and risk of carotid atherosclerosis

A simple formula to predict echocardiographic diastolic dysfunction—electrocardiographic diastolic index

Impact of postdischarge care fragmentation on clinical outcomes and survival following transcatheter aortic valve replacement

Haarkortisol als chronischer Stressparameter bei Patienten mit akutem ST-Strecken-Hebungs-Infarkt

Prognostic value of DCTA scoring system in heart failure